# Antioxidant Treatment of Type 2 Diabetes

> **NCT00609102** · EARLY_PHASE1 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 44 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Placebo
- **DRUG:** n-aceylcysteine

## Key facts

- **NCT ID:** NCT00609102
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2014-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00609102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00609102, "Antioxidant Treatment of Type 2 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00609102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*